Kidney Disease, Chronic Clinical Trials

11 recruiting

Kidney Disease, Chronic Trials at a Glance

12 actively recruiting trials for kidney disease, chronic are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Miami, St Louis, and Baltimore. Lead sponsors running kidney disease, chronic studies include Mansoura University, Instituto de Investigación Hospital Universitario La Paz, and Erasmus Medical Center.

Browse kidney disease, chronic trials by phase

Treatments under study

About Kidney Disease, Chronic Clinical Trials

Looking for clinical trials for Kidney Disease, Chronic? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Disease, Chronic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Disease, Chronic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled452 locationsNCT06531824
Recruiting
Phase 2

Testosterone Treatment in Men With Chronic Kidney Disease

Hypogonadism, MaleKidney Disease, Chronic
St. Louis University20 enrolled1 locationNCT05249634
Recruiting

Rutgers University Study of the Genetics of Kidney Disease

Kidney Disease, ChronicKidney DiseasesKidney Disease+3 more
Rutgers, The State University of New Jersey50,000 enrolled1 locationNCT07217535
Recruiting
Not Applicable

A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)

Kidney Disease, ChronicFrailtyKidney Failure
Seven Oaks Hospital Chronic Disease Innovation Centre54 enrolled2 locationsNCT06343727
Recruiting

KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection

Kidney Disease, ChronicKidney Transplant
University of Edinburgh200 enrolled2 locationsNCT06830473
Recruiting
Phase 3

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

Kidney Disease, Chronic
University Hospital, Clermont-Ferrand100 enrolled1 locationNCT07374042
Recruiting

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

Kidney Disease, ChronicKidney DiseasesKidney Failure
Wake Forest University Health Sciences5,000 enrolled18 locationsNCT03615235
Recruiting
Phase 4

Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

Kidney Disease, ChronicImmunosuppressionTransplant Recipient (Kidney)
Instituto de Investigación Hospital Universitario La Paz114 enrolled1 locationNCT06701825
Recruiting
Not Applicable

Diuretic Testing in Chronic Kidney Disease

Kidney Disease, Chronic
Erasmus Medical Center86 enrolled1 locationNCT06841692
Recruiting
Phase 1Phase 2

Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial

Kidney Disease, ChronicRenal Insufficiency, ChronicGut Dysbiosis+1 more
Mansoura University72 enrolled1 locationNCT06863194
Recruiting
Phase 2

Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients

Chronic Kidney Disease(CKD)Anemia, Kidney Disease, Chronic
Mansoura University80 enrolled1 locationNCT06897605
Recruiting

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

CancerDiabetes MellitusCardiovascular Diseases+4 more
The University of Hong Kong250,000 enrolled1 locationNCT05248412